ZG16B has been researched as a biomarker for the diagnosis and progression of many tumors, including pancreatic cancer and colon cancer (Lu et al., 2021), but its detailed biological function is also unknown. This evidence concerns the gene ZG16B and familial pancreatic carcinoma.